Tags : Medtronic

Weekly Snapshot

PharmaShots Weekly Snapshots (Dec 7-11, 2020)

Roche Launches Elecsys SARS-CoV-2 Antigen Test to Support High-Volume COVID-19 Testing Published: Dec 11, 2020 | Tags: Antigen, COVID-19, High, Laboratory, Launch, patients, Roche, SARS-CoV-2, Support, Suspected, Test, Testing, Volume Chugai In-Licenses Roche’s Antibody Cocktail for COVID-19 in Japan Published: Dec 10, 2020 | Tags: Casirivimab, Chugai, Commercialization, COVID-19, Development, Imdevimab, In-License Agreement, Japan, Roche, […]Read More

MedTech

Medtronic Launches Carpediem as the First Pediatric and Neonatal Acute

Shots: Following the US FDA’s approval granted in early 2020, the first Carpediem (Cardio-Renal Pediatric Dialysis Emergency Machine) were installed & use at Cincinnati Children’s HMC in the US Carpediem system is indicated for acute kidney injury or fluid overloaded patients requiring hemodialysis or hemofiltration therapy The system is intended to provide CRRT to patients […]Read More

Viewpoints

ViewPoints Interview: Medtronic’s Julie Foster Shares Insight on InPen Integrated

In a recent interview with PharmaShots, Julie Foster, Vice President, Global Customer Experience of the Diabetes business at Medtronic, shares information about recent and upcoming announcements for the company. Shots: The integration of real-time CGM data into the smart insulin pen app follows the acquisition of Companion Medical’s InPen to the Medtronic portfolio, as of Sept’2020 The […]Read More

Weekly Snapshot

PharmaShots Weekly Snapshots (Nov 09-13, 2020)

Qiagen Launches Portable Digital SARS-CoV-2 Antigen Test in the US Published: Nov 13,2020 | Tags: Antigen Test, Digital, Launches, Portable, Qiagen, SARS-CoV-2, US GSK and Medicago Initiate P-II/III Study of its Plant-Derived COVID-19 Vaccine Published: Nov 13,2020 | Tags: COVID-19, GSK, Initiate, Medicago, P-II/III, Plant- Derived study, vaccine BD Acquires the Medical Business Assets of […]Read More

MedTech

Medtronic Launches InPen Integrated with CGM Data for People with

Shots: The integration of real-time CGM data into the smart insulin pen app follows the acquisition of Companion Medical’s InPen to the Medtronic portfolio, as of Sept’2020 The integrated system provides real-time glucose readings alongside insulin dose information giving users everything they need to manage their diabetes through a single smartphone app InPen is the […]Read More

Weekly Snapshot

PharmaShots Weekly Snapshot (Nov 02-06, 2020)

AstraZeneca’s Brilinta (ticagrelor) Receives the US FDA’s Approval to Reduce the Risk of Stroke in Patients with an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack Published: Nov 6, 2020 | Tags: AstraZeneca, Brilinta, ticagrelor, Receives, US FDA, Approval, Acute, High,Risk, Transient, Ischaemic, Stroke Novo Nordisk to Acquire Emisphere Technologies for $1.8B Published: Nov 6, […]Read More

M&A MedTech

Medtronic to Acquire Avenu Medical

Shots: Medtronic acquires Avenu Medical for its Percutaneous Fistula Creation Technology that will foster Medtronic’s peripheral vascular access portfolio and improves outcomes for patients with ESRD undergoing dialysis. The acquisition is expected to close in Oct’2020 The acquisition allows Medtronic to bring less invasive, endovascular solutions to patients requiring durable vascular access. This marks the […]Read More

MedTech Regulatory

Medtronic’s MiniMed 770G Insulin Pump System with Smartphone Connectivity Receives

Shots: The US FDA has approved MiniMed 770G hybrid closed loop system, offering SmartGuard technology, with smartphone connectivity and an expanded age indication to children aged ≤2yrs., making it easier to access and share real-time CGM and pump data The system will enable caregivers to analyze data remotely on their smartphones, with proactive in-app notices […]Read More

Weekly Snapshot

Weekly Snapshot Aug 10 – 14, 2020

1. Roche’s Evrysdi (risdiplam) Receives the US FDA’s Approval for SMA in Adults and Children Published: Aug 10, 2020 | Tags: Roche, Evrysdi, risdiplam, Receives, US, FDA, Approval, SMA, Adults, Children 2.  The US FDA Approves Guardant360 CDx as the First Liquid Biopsy NGS Assay to Identify EGFR Mutations in Non-Small Cell Lung Cancer Published: Aug 07, […]Read More